Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Anatomic Stage I Breast Cancer AJCC v8 × Imlunestrant × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Specimen Handling 2 abemaciclib 1 Standard of Care 1 Practice Guidelines as Topic 1 Mental Status and Dementia Tests 1 Interviews as Topic 1 Imlunestrant 1 Goserelin 1 Exercise Test 1 Exercise 1 Accelerometry 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07191717 2025-11-10

Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

Jonsson Comprehensive Cancer Center

Phase 2 Not yet recruiting

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon ⚡